TITLE

Astellas Axes OSI, Perseid Units, Cuts Jobs in Japan

AUTHOR(S)
Powers, Marie
PUB. DATE
May 2013
SOURCE
BioWorld Today;5/15/2013, Vol. 24 Issue 93, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the restructuring efforts of Astelllas Paharma Inc. It reveals that the firm will close its U.S. units OSI Pharmaceuticals LLC and Perseid Therapeutics LLC in 2013 and will downsize Astellas Research Institute of America LLC. The article also informs that Astellas will fold the operations of its Kashima facility in Osaka, Japan into other sites, including its Tsukuba Research Center.
ACCESSION #
87646728

 

Related Articles

  • Astellas Makes Hostile Bid for OSI Pharma.  // Bioworld Week;3/8/2010, Vol. 18 Issue 10, p3 

    The article reports on the bid of Tokyo-based Astellas Pharma Inc. to buy out the Melville, New York-based OSI Pharmaceuticals Inc.

  • Business briefs. Golden, John // Westchester County Business Journal;6/21/2010, Vol. 49 Issue 25, p3 

    The article reports that OSI Pharmaceutical Inc. has been acquired by Astellas Pharma Inc. in New York.

  • Maxygen Reports 2nd Qtr 2011 Financial Results.  // Biomedical Market Newsletter;8/12/2011, Vol. 21, p588 

    The article focuses on the financial and business results of Redwood City, California-based biotech company Maxygen, Inc. for second quarter (Q2) of 2011 ending June 30. It mentions that Maxygen's attributable net income is 54.5 million dollar, which reflects the sale of discontinued operation...

  • Maxygen Has Maxi-Cash After Astellas Buyout of Perseid. Wall, Tom // BioWorld Today;3/18/2011, Vol. 22 Issue 53, p1 

    The article reports that Astellas Pharma Inc. has bought out 83.3. percent equity interest of Perseid Therapeutics LLC from Maxygen. Inc. for 76 million U.S. dollars in 2011. Perseid will become a wholly owned subsidiary of Astellas and will focus on protein pharmaceuticals programs acquired...

  • Astellas and Maxygen Announce Completion of Acquisition of Perseid by Astellas.  // Biomedical Market Newsletter;5/17/2011, p639 

    The article reports on the announcement of Astellas Pharma Inc. and Maxygen Inc. regarding the purchase completion of the Astellas to the equity interest of Maxygen to Perseid Therapeutics LLC that is worth 76.0 million U.S. dollar cash. It mentions that Astellas has given the right to acquired...

  • OSI Might Not Need Partner: Roche to Play White knight Roche to Play White Knight. Morrison, Trista // BioWorld Insight;3/22/2010, Vol. 18 Issue 12, p3 

    The article reports on the status of the proposed takeover of Astella Pharma Inc. by OSI Pharmaceuticals Inc. worth 3.5 billion dollars in the U.S. The move did not realize because OSI's board of directors rejected the hostile proposal, while the firm responded by having its own line up of...

  • OSI project haited in wake of takeover. Golden, John // Westchester County Business Journal;6/28/2010, Vol. 49 Issue 26, p3 

    The article reports on the shutdown in construction of the relocation project of OSI Pharmaceuticals Inc. at Ardsley Park Science and Technology Center in Greenburg, New York. It states that the shutdown has resulted in layoffs for hundred of building trades workers. It mentions that the company...

  • OSI move scuttled. Golden, John // Westchester County Business Journal;8/9/2010, Vol. 49 Issue 32, p1 

    The article reports on the plan of pharmaceutical company Astellas Pharma Inc. not to complete the relocation of OSI Pharmaceuticals Inc. to the Ardsley Park Science and Technology Center in Greenburgh, New York. Maribeth Landwehr of Astellas notes their hope to minimize uncertainty as they...

  • Astellas Makes Hostile Bid for OSI; Will Roche Take the Bait? Boggs, Jennifer // BioWorld Today;3/2/2010, Vol. 21 Issue 40, p1 

    The article reports on the hostile bid of Astellas Pharma Inc. after its verbal offer to buy OSI Pharmaceuticals Inc. for 52 U.S. dollars a share failed to entice the company's board in February 2010. It notes that Astellas should increase its bid because the shares of OSI increased by 52% on...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics